416
Views
11
CrossRef citations to date
0
Altmetric
Articles

Mental health comorbidities and cost/utilization outcomes in head and neck cancer patients

, PhD, , MD, MBA, , MPA & , MD, PhP

References

  • National Cancer Institute, Surveillance, Epidemiology, and End Results Program, https://seer.cancer.gov/faststats/. Accessed May 16, 2018.
  • National Cancer Institute, Cost Projections. https://costprojections.cancer.gov/. Accessed May 16, 2018.
  • Chan JY, Semenov YR, Gourin CG. Postoperative urinary tract infection and short-term outcomes and costs in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2013;148(4):602–610. doi: 10.1177/0194599812474595.
  • de Souza JA, Santana IA, de Castro G, Jr, de Lima Lopes G, Jr, Tina Shih YC. Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspective. Int J Radiat Oncol Biol Phys. 2014;89(5):989–996. doi: 10.1016/j.ijrobp.2014.03.040
  • Wissinger E, Griebsch I, Lungershausen J, Byrnes M, Travers K, Pashos CL. The humanistic burden of head and neck cancer: a systematic literature review. Pharmacoeconomics 2014;32(12):1213–1229. doi: 10.1007/s40273-014-0199-x
  • Gourin CG, Dy SM, Herbert RJ, et al. Treatment, survival, and costs of laryngeal cancer care in the elderly. Laryngoscope 2014;124(8):1827–1835. doi: 10.1002/lary.24574.
  • Genther DJ, Gourin CG. Effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly. Head Neck. 2015;37(5):685–693. doi: 10.1002/hed.23651.
  • Enomoto LM, Schaefer EW, Goldenberg D, Mackley H, Koch WM, Hollenbeak CS. The cost of hospice services in terminally ill patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2015;141(12):1066–1074. doi: 10.1001/jamaoto.2015.2162.
  • Klussmann JP, Schadlich PK, Chen X, Remy V. Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany. Clinicoecon Outcomes Res. 2013;5:203–213. doi: 10.2147/CEOR.S43393
  • Kurzweg T, Knecht R. Inventory of economic evaluation of head and neck oncology from the German perspective. Eur Arch Otorhinolaryngol. 2014;271(10):2611–2616. doi: 10.1007/s00405-013-2878-1.
  • Welch CA, Czerwinski D, Ghimire B, Bertsimas D. Depression and costs of health care. Psychosomatics 2009;50(4):392–401. doi: 10.1176/appi.psy.50.4.392.
  • Rieke K, Boilesen E, Lydiatt W, Schmid KK, Houfek J, Watanabe-Galloway S. Population-based retrospective study to investigate preexisting and new depression diagnosis among head and neck cancer patients. Cancer Epidemiol. 2016;43:42–48. doi: 10.1016/j.canep.2016.06.008.
  • Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K. A longitudinal study of depressive symptoms in patients with head and neck cancer undergoing radiotherapy. Cancer Nurs. 2015;38(6):436–446. doi: 10.1097/NCC.0000000000000225.
  • Jeffery DD, Linton A. The impact of depression as a cancer comorbidity: rates, health care utilization, and associated costs. Community Oncology. 2012;9(7):216–221. https://www.mdedge.com/sites/default/files/issues/articles/6_CO_july_216_Jeffrey.pdf
  • Neilson K, Pollard A, Boonzaier A, et al. A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology 2013;22(8):1843–1848. doi: 10.1002/pon.3228.
  • Joseph LA, Routledge JA, Burns MP, et al. Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients. J Laryngol Otol. 2013;127(03):285–294. doi: 10.1017/S0022215113000078.
  • Barber B, Dergousoff J, Nesbitt M, et al. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study. J Otolaryngol Head Neck Surg. 2015;44(1):38. doi: 10.1186/s40463-015-0092-4.
  • Ghiggia A, Castelli L, Riva G, et al. Psychological distress and coping in nasopharyngeal cancer: an explorative study in Western Europe. Psychol Health Med. 2017;22(4):449–461. doi: 10.1080/13548506.2016.1220600.
  • Henry M, Rosberger Z, Ianovski LE, et al. A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post-treatment: longitudinal study. Psychooncology 2018. doi: 10.1002/pon.4705. [Epub ahead of print]
  • Rieke K, Schmid KK, Lydiatt W, Houfek J, Boilesen E, Watanabe-Galloway S. Depression and survival in head and neck cancer patients. Oral Oncol. 2017;65:76–82. doi: 10.1016/j.oraloncology.2016.12.014.
  • Posluszny DM, Dougall AL, Johnson JT, et al. Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partners. Head Neck. 2015;37(9):1282–1289. doi: 10.1002/hed.23760.
  • Chen AM, Hsu S, Felix C, Garst J, Yoshizaki T. Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation. Laryngoscope 2018;128(3):641–645. doi: 10.1002/lary.26751.
  • Devins GM, Payne AY, Lebel S, et al. The burden of stress in head and neck cancer. Psychooncology 2013;22(3):668–676. doi: 10.1002/pon.3050.
  • Badr H, Gupta V, Sikora A, Posner M. Psychological distress in patients and caregivers over the course of radiotherapy for head and neck cancer. Oral Oncol. 2014;50(10):1005–1011. doi: 10.1016/j.oraloncology.2014.07.003.
  • Mason H, DeRubeis MB, Burke N, et al. Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: a review of the literature and areas for future research. Wjco. 2016;7(2):220–226. doi: 10.5306/wjco.v7.i2.220.
  • Simcock R, Simo R. Follow-up and survivorship in head and neck cancer. Clin Oncol (R Coll Radiol). 2016;28(7):451–458. doi: 10.1016/j.clon.2016.03.004.
  • Chen AM, Daly ME, Vazquez E, et al. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg. 2013;139(9):885–889. doi: 10.1001/jamaoto.2013.4072.
  • Rhoten BA, Deng J, Dietrich MS, Murphy B, Ridner SH. Body image and depressive symptoms in patients with head and neck cancer: an important relationship. Support Care Cancer. 2014;22(11):3053–3060. doi: 10.1007/s00520-014-2312-2
  • Howren MB, Christensen AJ, Karnell LH, Funk GF. Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol. 2013;81(2):299–317. doi: 10.1037/a0029940.
  • Henry M, Habib LA, Morrison M, et al. Head and neck cancer patients want us to support them psychologically in the posttreatment period: survey results. Pall Supp Care. 2014;12(06):481–493. doi: 10.1017/S1478951513000771.
  • Paleri V, Wight RG, Silver CE, et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol. 2010;46(10):712–719. doi: 10.1016/j.oraloncology.2010.07.008.
  • Genther DJ, Gourin CG. The effect of alcohol abuse and alcohol withdrawal on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope 2012;122(8):1739–1747. doi: 10.1002/lary.23348.
  • Laurence B, Mould-Millman NK, Nero KE, Jr, Salter RO, Sagoo PK. Depression and hospital admission in older patients with head and neck cancer: analysis of a national healthcare database. Gerodontology 2017;34(2):284–287. doi: 10.1111/ger.12247.
  • Reyes-Gibby CC, Melkonian SC, Hanna EY, et al. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017;39(6):1195–1204. doi: 10.1002/hed.24748.
  • Mausbach BT, Irwin SA. Depression and healthcare service utilization in patients with cancer. Psychooncology 2017;26(8):1133–1139. doi: 10.1002/pon.4133.
  • Yi JC, Syrjala KL. Anxiety and depression in cancer survivors. Med Clin North Am. 2017;101(6):1099–1113. doi: 10.1016/j.mcna.2017.06.005.
  • Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2–3):343–351. doi: 10.1016/j.jad.2012.03.025.
  • Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw. 2010;8(4):448–485.
  • Drug Demand Reduction Program, Office of the Under Secretary for Personnel and Readiness, Department of Defense, http://prhome.defense.gov/Readiness/ForceResiliency/DDRP/. Accessed May 16, 2018.
  • Jeffery DD, May L, Luckey B, Balison BM, Klette KL. Use and abuse of prescribed opioids, central nervous system depressants, and stimulants among U.S. active duty military personnel in FY2010. Mil Med. 2014;179(10):1141–1148. doi: 10.7205/MILMED-D-14-00002.
  • Morton RP, Davies AD, Baker J, Baker GA, Stell PM. Quality of life in treated head and neck cancer patients: a preliminary report. Clin Otolaryngol Allied Sci. 1984;9(3):181–185.
  • Ghazali N, Roe B, Lowe D, et al. Screening for distress using the distress thermometer and the University of Washington Quality of Life in post-treatment head and neck cancer survivors. Eur Arch Otorhinolaryngol. 2017;274(5):2253–2260. doi: 10.1007/s00405-017-4474-2.
  • Williams C. Psychosocial distress and distress screening in multidisciplinary head and neck cancer treatment. Otolaryngol Clin North Am. 2017;50(4):807–823. doi: 10.1016/j.otc.2017.04.002.
  • Pickard AS, Jiang R, Lin HW, Rosenbloom S, Cella D. Using patient-reported outcomes to compare relative burden of cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in eleven types of cancer. Clin Ther. 2016;38(4):769–777. doi: 10.1016/j.clinthera.2016.03.009.
  • Semple C, Parahoo K, Norman A, McCaughan E, Humphris G, Mills M. Psychosocial interventions for patients with head and neck cancer. Cochrane Database Syst Rev. 2013;16(7):CD009441. doi: 10.1002/14651858.CD009441.pub2.
  • Krebber AM, Jansen F, Witte BI, et al. IM. Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trial. Ann Oncol. 2016;27(9):1754–1760. doi: 10.1093/annonc/mdw230.
  • Kadan-Lottick NS, Vanderwerker LC, Block SD, Zhang B, Prigerson HG. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer 2005;104(12):2872–2881. doi: 10.1002/cncr.21532.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.